Streetbeat News

Stock Prices

RGLS

TECH

Bio-Techne and Regulus Therapeutics have announced the continuation of their technical and clinical collaboration following positive topline results from the second cohort of Regulus' Phase 1B study of RGLS8429 for Autosomal Dominant Polycystic Kidney Disease.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:11 am

CAE

CAE shares are trading lower after the company reported a year-over-year decrease in preliminary Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:10 am

ICLK

iClick Interactive has received a NASDAQ deficiency notice due to a delayed filing of its Form 20-F. This could have short-term implications for the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:09 am

SHOP

Shopify shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $67 to $74.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:08 am

PDD

PDD Holdings shares are trading higher following a Q1 earnings beat. The stock initially fell on the report but has rebounded.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:08 am

FREY

FREYR Battery has completed its first production trial at the Customer Qualification Plant (CQP), marking a significant milestone in giga scale lithium-ion manufacturing. This positions FREYR as a leading partner in advanced lithium-ion battery production technologies.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:07 am

AVIR

Atea Pharmaceuticals announced it will present new data showcasing the potential best-in-class combination profile of Bemnifosbuvir and Ruzasvir for the treatment of Hepatitis C Virus at the EASL Congress 2024.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:06 am

PBI

Pitney Bowes announced that a new process is commencing to appoint its next permanent CEO, as the previous process run by the prior board did not result in a successful appointment.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:06 am

WOOF

Petco Health and Wellness expects Q2 net revenue of approximately $1.525 billion, slightly above the consensus estimate of $1.52 billion. The company also anticipates an adjusted EPS of $(0.02), which aligns with the consensus estimate.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:06 am

BRC

Brady Corporation (BRC) has raised its adjusted FY24 EPS guidance from $3.95 - $4.10 to $4.08 - $4.15, surpassing the $3.99 estimate.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 11:05 am